IGF2 and neoplasm: Similarly, local anti-IGF2 antibody treatment significantly decreased oHSV therapy-induced recruitment of Ly6G + neutrophils/PMN-MDSCs in DB7 BCBM tumor-bearing mice (Supplementary Fig. S4).